2025

Asger Bach Lund: Center for Clinical Metabolic Research - Søborg, Denmark
Pancreatic Polypeptide as a Modulator of Amylin-Induced Satiety in Humans

Carolin Daniel: Helmholtz Munich and LMU Munich - Neuherberg, Germany
Identification and characterization of early Treg impairments prior to islet autoimmunity onset

Carolina Brito-Lobato: University of Copenhagen - Denmark 
Biased GLP-1R Agonism and GIPR Co-Agonism: Mechanistic Insights into ß-Cell Secretion

Diego Balboa: University of Helsinki - Finland
Precision Genome Editing for In Vivo Correction of Monogenic Diabetes

Jorge Alegre-Cebollada: Spanish National Center for Cardiovascular Research - Madrid, Spain
A new method to uncover crosslinking glycations as a therapeutic target in diabetic cardiomyopathy

Martijn Brouwers: Maastricht University - Netherlands
The effects of gastrointestinal transit on fructose-mediated MASLD and type 2 diabetes

Sander W. van der Laan: UMC Utrecht - Netherlands
SugarPlaque

Sophia Maschalidi: Nova Institute for Medical Systems Biology - Lisbon, Portugal
Metabolic signatures of pancreatic fat: predicting ß-cell decline and diabetes progression

Susanne Mandrup: University of Southern Denmark - Odense M, Denmark
Profiling enhancer activity to uncover transcriptional regulation in isolated human adipocytes

Teresa Mezza: Catholic University of Rome - Italy
Metabolic signatures of pancreatic fat: predicting ß-cell decline and diabetes progression

2024

Anika Böttcher: Helmholtz Center Munich - Germany
Dissecting the regulatory relationship between WNT/PCP signaling and FOXJ1 function in pancreatic endocrinogenesis

Christian Göbl: Medical University of Vienna - Austria
Phenotypes of Gestational Diabetes Mellitus and their heterogeneity in insulin action and beta-cell function

Daniel Coral: Lund University Diabetes Centre - Malmö, Sweden
Modelling of eGFR trajectories to dissect CKD heterogeneity and response to treatment

Erez Dror: The Hebrew University-Hadassah Medical School - Jerusalem, Israel
Ad hoc investigation of islet-immune cell influence on islet function

Laura Marroquí: Miguel Hernandez University of Elche - Spain
Targeting IFNα pathway with protein-protein interaction inhibitors as a therapeutic strategy for T1D

Lorella Marselli: University of Pisa - Italy
Peripancreatic adipose tissue and its impact on islet beta cells in human type 2 diabetes

Mostafa Bakhti: Institute of Diabetes and Regeneration Research (IDR) - Helmholtz Munich , Germany
Decoding Tubulin Code in ß-Cells: The Role of Acetylated Tubulin and HDAC6 in Regulating Insulin Secretion

Nils Wierup: Lund University - Malmö, Sweden
Studies in enteroendocrine cells to identify targets for the treatment of type 2 diabetes

Rashmi Prasad: Lund University - Malmö, Sweden
Investigating allelic imbalance in expression in human pancreatic islets and parent-of-origin effects on insulin deficiency and type 2 diabetes risk

Zoltan Kender: Heidelberg University Hospital - Germany
The Role of Blood-Nerve Barrier Integrity and Metabolic Associated Steatotic Liver Disease in Diabetic Neuropathy

2023

Anna Krook: Karolinska Institutet - Stockholm, Sweden
Extracellular Vesicle lipidome in people with type 2 diabetes

Bruno Guigas: Leiden University Medical Center - Leiden, Netherlands
Sugar kisses: investigating the role of glycans in adipocyte-macrophage crosstalk during obesity

Domenico Trico: University of Pisa - Italy
Deciphering the role of incretin hormones in weight loss-induced remisson of type 2 diabetes

Esteban Nicolas Gurzov: Free university of Brussels (Université libre de Bruxelles, ULB) - Brussels, Belgium
Inhibition of receptor protein tyrosine phosphatases provides a novel strategy for the treatment of diabetes

Jens Juul Holst: University of Copenhagen - Denmark
GLP-1 is safe from hypoglycaemia, but why?

Juleen R. Zierath: Karolinska Institutet - Stockholm, Sweden
Circadian transcription in type 2 diabetes

Julien Diana: Necker Institute for Sick Children (INEM) - Paris, France
Breast milk borne antimicrobial peptides in type 1 diabetes

Marc Claret: Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS) - Barcelona, Spain
Decoding tanycytic mitochondrial dynamics in nutrient sensing and metabolic health

Mario Galgani: University of Naples - Italy
Soluble PD-1: shedding light on an overlooked player in the progression of type 1 diabetes

Mette Marie Rosenkilde: University of Copenhagen - Denmark
Molecular determinants for ligand-mediated selective receptor actions

2022

Åke Sjöholm: University of Gävle - Sweden
Discovery and characterization of a novel type of monogenic diabetes in patients with Welander distal myopathy

Catherine Arden: Newcastle University - UK
Elucidating the mechanisms underlying glucose regulated autophagy in pancreatic beta cells

Carolina Hagberg: Karolinska Institute - Stockholm, Sweden
Prevention of adipocyte dysfunction and metabolic disease via metabolic targeting of adipose tissue

Dimitri Van Simaeys: Karolinska Institute - Stockholm, Sweden
Beta cell-targeting aptamer-small activating RNA-chimera in islet transplantation and regeneration

Heikki Hyöty: Tampere University - Finland
Weak innate immune response as a risk factor for enterovirus persistence and insulin-initiated islet autoimmunity

Jacinto López Sagaseta: Navarrabiomed - Pamplona, Spain
Structural bases for the fate and pathogenicity of autoreactive t-cells in type 1 diabetes

Jonatan Bagger: University of Copenhagen - Denmark
The role of amylin in bone metabolism

Kashyap Patel: University of Exeter - UK
Redefining the genetic landscape of MODY

Rashmi Prasad: Lund University - Sweden
Dissecting the genetic and phenotypic profile of potential subtypes of gestational diabetes and postpartum diabetes

Shane Browne: University of Medicine and Health Sciences - Dublin, Ireland
A peptide-decorated anti-microbial and pro-healing hyaluronic acid dressing to promote diabetic wound healing

Tuomas Kilpeläinen: University of Copenhagen - Denmark
Identifying gene-physical activity interactions in type 2 diabetes by a reverse, targeted approach

2021

Christian Herder: German Diabetes Centre - Düsseldorf, Germany
Novel proteomics-based approach for the prediction of distal sensorimotor polyneuropathy

Eran Elinav: Weizmann Institute of Science - Rehovot, Israel
Decoding the mechanisms driving increased diabetic risk for pulmonary infection and complications

Fanny Langlet: University of Lausanne - Switzerland
Role of hypothalamic tanycytes in synaptic plasticity for the control of energy balance and glucose homeostasis

Jo Lewis: University of Cambridge - UK
The role of gut-derived GIP in the regulation of food intake and body weight

Karin Jandeleit-Dahm: German Diabetes Centre - Düsseldorf, Germany
Combating diabetic nephropathy by targeting the NADPH oxidase NOX5

Olof Idevall Hagren: Uppsala University - Sweden
Cyclic nucleotide signalling in the beta cell primary cilium

Oluf Pedersen: Copenhagen University Hospital - Denmark
First in human study of metabolic effects of a newly discovered polypeptide hormone

Sanna Lehtonen: University of Helsinki - Finland
Targeting renal cell energy metabolism and stress endurance to protect from diabetic kidney disease

2020

Dinesh Selvarajah: University of Sheffield - UK
PET-mRi study Of NEuronal Activation in painful Diabetic Neuropathy (PETRONELA-DN)

Jens J. Holst: University of Copenhagen - Denmark
Mechanisms underlying glucose-regulated glucagon secretion

Jorma Toppari: University of Turku - Finland
Molecular pathways of innate immune system linked to type 1 diabetes

Mette Rosenkilde: University of Copenhagen - Denmark
Impact of naturally occuring GIP receptor variants in obesity and diabetes

Olof Eriksson: Uppsala University - Sweden
PET imaging of liver fibrosis in NASH

Paul Caton: King's College London - UK
Using small-molecule modulators of eNAMPT to improve functional beta-cell mass in type 1 diabetes

Sophie Croizier: University of Lausanne - Switzerland
EphrinB3 and excitability of hypothalamic POMC neurons in type 2 diabetes

Vera Schrauwen-Hinderling: Maastricht University - Netherlands
Hepatic fat; it is not all about quantity, quality matters!